These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33745988)

  • 41. Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.
    Bade BC; DeRycke EC; Ramsey C; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Brandt C; Bastian LA; Akgün KM
    Ann Am Thorac Soc; 2019 Jun; 16(6):707-714. PubMed ID: 30822098
    [No Abstract]   [Full Text] [Related]  

  • 42. Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease.
    Martinez CH; Raparla S; Plauschinat CA; Giardino ND; Rogers B; Beresford J; Bentkover JD; Schachtner-Appel A; Curtis JL; Martinez FJ; Han MK
    J Womens Health (Larchmt); 2012 Dec; 21(12):1267-74. PubMed ID: 23210491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and molecular markers in COPD.
    Gonçalves I; Guimarães MJ; van Zeller M; Menezes F; Moita J; Simão P;
    Pulmonology; 2018; 24(4):250-259. PubMed ID: 29898875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reflecting the changing face of chronic obstructive pulmonary disease: sex and gender in public education materials on COPD.
    Pederson AP; Hoyak KA; Mills S; Camp PG
    Proc Am Thorac Soc; 2007 Dec; 4(8):683-5. PubMed ID: 18073403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sex discrepancies in COPD patients and burden of the disease in females: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study).
    Papaioannou AI; Bania E; Alexopoulos EC; Mitsiki E; Malli F; Gourgoulianis KI
    Int J Chron Obstruct Pulmon Dis; 2014; 9():203-13. PubMed ID: 24600217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. "Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.".
    Corlateanu A; Mendez Y; Wang Y; Garnica RJA; Botnaru V; Siafakas N
    Pulmonology; 2020; 26(2):95-100. PubMed ID: 31740261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What does endotyping mean for treatment in chronic obstructive pulmonary disease?
    Agustí A; Celli B; Faner R
    Lancet; 2017 Sep; 390(10098):980-987. PubMed ID: 28872030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. From proteomics to prescription-the search for COPD biomarkers.
    Nicholas BL; O'Connor CD; Djukanovic R
    COPD; 2009 Aug; 6(4):298-303. PubMed ID: 19811390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study.
    Wedzicha JA; Singh D; Tsiligianni I; Jenkins C; Fucile S; Fogel R; Shen S; Goyal P; Mezzi K; Kostikas K
    Respir Res; 2019 Jan; 20(1):4. PubMed ID: 30621717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The matrikine PGP as a potential biomarker in COPD.
    Abdul Roda M; Fernstrand AM; Redegeld FA; Blalock JE; Gaggar A; Folkerts G
    Am J Physiol Lung Cell Mol Physiol; 2015 Jun; 308(11):L1095-101. PubMed ID: 26033353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
    Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J;
    Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbation.
    Cydulka RK; Rowe BH; Clark S; Emerman CL; Rimm AR; Camargo CA
    Acad Emerg Med; 2005 Dec; 12(12):1173-9. PubMed ID: 16282511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac Biomarkers in the Identification of Future Risk in Chronic Obstructive Pulmonary Disease.
    Jahn K; Papakonstantinou E; Stolz D
    Curr Top Med Chem; 2016; 16(14):1539-49. PubMed ID: 26420369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gender and chronic obstructive pulmonary disease: why it matters.
    Han MK; Postma D; Mannino DM; Giardino ND; Buist S; Curtis JL; Martinez FJ
    Am J Respir Crit Care Med; 2007 Dec; 176(12):1179-84. PubMed ID: 17673696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
    Singh D; Roche N; Halpin D; Agusti A; Wedzicha JA; Martinez FJ
    Am J Respir Crit Care Med; 2016 Sep; 194(5):541-9. PubMed ID: 27585383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls.
    Hou C; Zhao H; Liu L; Li W; Zhou X; Lv Y; Shen X; Liang Z; Cai S; Zou F
    Mol Med; 2011; 17(7-8):807-15. PubMed ID: 21380479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Personalised Medicine for Asthma and Chronic Obstructive Pulmonary Disease.
    Heaney LG; McGarvey LP
    Respiration; 2017; 93(3):153-161. PubMed ID: 28110335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Features Of Women With COPD: Sex Differences In A Cross-Sectional Study In Spain ("The ESPIRAL-ES Study").
    Trigueros JA; Riesco JA; Alcázar-Navarrete B; Campuzano A; Pérez J
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2469-2478. PubMed ID: 31806956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gender and asthma-chronic obstructive pulmonary disease overlap syndrome.
    Wheaton AG; Pleasants RA; Croft JB; Ohar JA; Heidari K; Mannino DM; Liu Y; Strange C
    J Asthma; 2016 Sep; 53(7):720-31. PubMed ID: 27043854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.
    Mohammad Y; Shaaban R; Al-Zahab BA; Khaltaev N; Bousquet J; Dubaybo B
    Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.